Hydrogen-rich saline inhibits NLRP3 inflammasome activation and attenuates experimental acute pancreatitis in mice.
Jian-Dong Ren, Jie Ma, Jun Hou, Wen-Jin Xiao, Wei-Hua Jin, Juan Wu, Kai-Hua Fan · Mediators of inflammation · 2014
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In mice, only at the higher doses (4 and 8 mL/kg × 3), HRS conferred favorable histopathological changes in pancreatic tissues, mainly characterized by reduced cytoplasmic vacuole generation, alleviated inflammatory infiltration, and parenchyma necrosis, which was paralleled with lower histopathological scores (Figures 4(a) and 4(b) ). These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in mice. Only at the higher doses (4 and 8 mL/kg × 3), HRS conferred favorable histopathological changes in pancreatic tissues, mainly characterized by reduced cytoplasmic vacuole generation, alleviated inflammatory infiltration, and parenchyma necrosis, which was paralleled with lower histopathological scores (Figures 4(a) and 4(b) ).
What the Researchers Studied
The researchers studied mice. The study used a preclinical animal experiment. The comparison condition was control condition or baseline measurements.
What Effects Did Molecular Hydrogen Have?
In brief, H₂ gas (0.4 MPa) was dissolved in normal saline (NS) for 6 hours to achieve a concentration of 0.6 mmol/L, and the concentration of H₂ in NS was detected using a dissolved hydrogen analyzer (DH-35A; DKKTOA, Tokyo, Japan). Only at the higher doses (4 and 8 mL/kg × 3), HRS conferred favorable histopathological changes in pancreatic tissues, mainly characterized by reduced cytoplasmic vacuole generation, alleviated inflammatory infiltration, and parenchyma necrosis, which was paralleled with lower histopathological scores (Figures 4(a) and 4(b) ). The authors concluded that in conclusion, the study has, for the first time, revealed that inhibition of the activation of NLRP3 inflammasome probably contributed to the therapeutic potential of HRS in AP.
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was mice. The study used a preclinical animal experiment.
Limitations and Safety
No separate limitations or safety findings were identified in the source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.